PATENT CLAIM ANALYSIS

Application Number: 16184922
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "597000"]

Abstract:
The present disclosure relates to the field of treatment of an orphan disease, in particular treatment of vascular Ehlers-Danlos syndrome (vEDS). More specifically, the present disclosure relates to novel up-titration dosage regimens (e.g., escalating dosage regimens) effective for treating vEDS patients with celiprolol.

Claim (Index 16):
The method of  claim 13 , wherein at least a 270 to 330 mg daily dose increase is made within six months.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14307195', '15520864', '15181526', '16030141', '13966229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7084861575222215
- 35 USC 102 Novelty (BERT): 0.5243055749316965
- Combined Prediction Score: 0.690068099263169
- Mean Citation Score: 253.93377199999995
- Max Citation Score: 258.25793
- Similarity Product: 149.79701469524562

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test